• Roberta Razzetti, Marco Bergamaschi, Gino Villetti, Piertonino Bolzoni, Maurizio Civelli, Ferruccio Berti, and Giuseppe Rossoni.
• Department of Pharmacology, Chiesi Farmaceutici S.p.A., Via Palermo 26/A, 43100 Parma, Italy. r.razzetti@chiesigroup.com
• Pharmacol. Res. 2007 May 1; 55 (5): 426-32.

AbstractThese studies were designed to assess the pharmacodynamic interaction between formoterol and beclomethasone dipropionate (BDP) in controlling the bronchoconstriction and inflammatory response induced by various challenges in guinea-pigs and rats. In anaesthetised guinea-pigs, superfusion of the formoterol/BDP combination into the tracheal lumen had significantly more effect than the single components in antagonising the bronchoconstricting and inflammatory responses to acetylcholine or ovalbumin in a standard model of airway hyper-responsiveness. After ovalbumin challenge, the combination completely protected animals from death at doses lower than those effective when given separately. The combination, at doses ineffective individually, even counteracted the development of lung oedema induced by sephadex in the rat. Finally, in tracheal strips from ovalbumin-sensitised guinea-pigs pre-treatment with BDP (30 mg kg(-1) i.m.) completely reversed the rightward shift of the formoterol dose-response curve due to beta(2)-receptor desensitisation. In conclusion, these results indicate that formoterol and BDP together induce a favourable pharmacodynamic interaction which can be considered more than additive, at least in these experimental settings.

49 keywords...

hide…